These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1688477)

  • 1. Hyperinnervation of surviving neurons of the human basal nucleus of meynert by galanin in dementias of Alzheimer's and Parkinson's disease.
    Chan-Palay V
    Adv Neurol; 1990; 51():253-5. PubMed ID: 1688477
    [No Abstract]   [Full Text] [Related]  

  • 2. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 4. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease.
    Kowall NW; Beal MF
    Neurosci Lett; 1989 Mar; 98(1):118-23. PubMed ID: 2469045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
    Nakano I; Hirano A
    Ann Neurol; 1984 May; 15(5):415-8. PubMed ID: 6732189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H; Iizuka R
    Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract]   [Full Text] [Related]  

  • 7. Note on the pathology of the basal nucleus of Meynert in degenerative brain disorders.
    Tagliavini F; Pilleri G
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(2):277-80. PubMed ID: 6240766
    [No Abstract]   [Full Text] [Related]  

  • 8. The nucleus basalis of Meynert in neurological disease: a quantitative morphological study.
    Rogers JD; Brogan D; Mirra SS
    Ann Neurol; 1985 Feb; 17(2):163-70. PubMed ID: 3883886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.
    Beal MF; MacGarvey U; Swartz KJ
    Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nucleus basalis of Meynert.
    Ezrin-Waters C; Resch L
    Can J Neurol Sci; 1986 Feb; 13(1):8-14. PubMed ID: 2937514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes within the basal nucleus in Parkinson's disease.
    Ulfig N; Braak E; Braak H
    Prog Clin Biol Res; 1989; 317():493-500. PubMed ID: 2690110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal communication breakdown in neurotransmitter systems in Alzheimer's and Parkinson's dementias.
    Chan-Palay V
    J Neurocytol; 1990 Oct; 19(5):802-6. PubMed ID: 1706418
    [No Abstract]   [Full Text] [Related]  

  • 14. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
    J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The basal nucleus of Meynert in idiopathic Parkinson's disease.
    Tagliavini F; Pilleri G; Bouras C; Constantinidis J
    Acta Neurol Scand; 1984 Jul; 70(1):20-8. PubMed ID: 6475484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calbindin D-28k and monoamine oxidase A immunoreactive neurons in the nucleus basalis of Meynert in senile dementia of the Alzheimer type and Parkinson's disease.
    Chan-Palay V; Höchli M; Savaskan E; Hungerecker G
    Dementia; 1993; 4(1):1-15. PubMed ID: 8358501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer's disease and Meynert's nucleus basalis. An anatomo- clinical point of view].
    Brion S; Plas J; Massé G
    Encephale; 1986; 12(3):111-4. PubMed ID: 3769856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered lipofuscin pigmentation in the basal nucleus (Meynert) in Parkinson's disease.
    Ulfig N
    Neurosci Res; 1989 Jun; 6(5):456-62. PubMed ID: 2771203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease.
    Pearson RC; Powell TP
    J Neural Transm Suppl; 1987; 24():139-46. PubMed ID: 3119773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders.
    Alexandris AS; Walker L; Liu AKL; McAleese KE; Johnson M; Pearce RKB; Gentleman SM; Attems J
    Neuropathol Appl Neurobiol; 2020 Apr; 46(3):264-278. PubMed ID: 31454423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.